Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works
Interferon beta (IFNβ) and glatiramer acetate (GA) were the first immunomodulators approved to the treatment of relapsing-remitting multiple sclerosis (MS) and clinically isolated syndromes. Despite the enlargement of the therapeutic armamentarium, IFNβ and GA remain the most widely drugs and the th...
Saved in:
| Main Authors: | Amélia Mendes, Maria José Sá |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações
2011-06-01
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2011000400024&lng=en&tlng=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical response to interferon beta and glatiramer acetate in multiple sclerosis patients: a Brazilian cohort
by: Valéria Coelho Santa Rita Pereira, et al.
Published: (2012-10-01) -
Recomendações quanto ao uso de drogas imunomoduladoras na esclerose múltipla: o consenso do BCTRIMS Recommendations for the use of immunomodulatory drugs in multiple sclerosis: the BCTRIMS consensus
by: CHARLES PETER TILBERY, et al.
Published: (2000-09-01) -
Patients’ satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis
by: Caroline Vieira Spessotto, et al.
Published: (2016-08-01) -
Influence of treatment in multiple sclerosis dysability: an open, retrospective, non-randomized long-term analysis Influência do tratamento na incapacidade da esclerose múltipla: estudo aberto, retrospectivo e não randomizado em longo prazo
by: Lineu Cesar Werneck, et al.
Published: (2010-08-01) -
Medication withdrawal may be an option for a select group of patients in relapsing-remitting multiple sclerosis
by: Guilherme Sciascia do Olival, et al.
Published: (2013-08-01)